GENinCode Plc (LON:GENI – Get Free Report)’s stock price was up 3.7% on Thursday . The stock traded as high as GBX 7 ($0.09) and last traded at GBX 7 ($0.09). Approximately 91 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 237,719 shares. The stock had previously closed at GBX 6.75 ($0.09).
GENinCode Stock Performance
The company has a debt-to-equity ratio of 23.20, a current ratio of 1.28 and a quick ratio of 15.89. The stock has a market cap of £12.39 million, a P/E ratio of -100.00 and a beta of 0.66. The stock has a 50-day simple moving average of GBX 6.54 and a 200-day simple moving average of GBX 6.61.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Read More
- Five stocks we like better than GENinCode
- What is the S&P/TSX Index?
- Emerging Markets: What They Are and Why They Matter
- Why Invest in 5G? How to Invest in 5G Stocks
- Recession or Not, These 3 Stocks Are Winners
- What is MarketRank™? How to Use it
- Why NVIDIA Is More of a Screaming Buy Than Ever
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
